INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2016 to Q4 2025

Type / Class
Equity / PHARMACEUTICALS
Symbol
PJP
Price per share
$104.54
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
638,030
Total reported value
$59,014,644
% of total 13F portfolios
0%
Share change
-274
Value change
+$125,900
Number of holders
93
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 30 Sep 2025, 93 institutional investors reported holding 638,030 shares of INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP).

Institutional Holders of INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 8,000 $835,363 $104.54 4
2025 Q3 638,030 $59,014,644 +$125,900 $92.49 93
2025 Q2 648,304 $51,793,796 -$4,348,336 $79.87 92
2025 Q1 686,556 $59,329,046 -$7,420,790 $86.61 96
2024 Q4 770,995 $63,735,490 +$914,486 $82.62 93
2024 Q3 759,068 $65,987,834 -$1,448,850 $86.97 97
2024 Q2 764,076 $62,890,046 -$3,635,998 $82.21 88
2024 Q1 818,775 $65,620,158 +$8,558,829 $80.16 92
2023 Q4 618,699 $47,087,841 -$3,528,274 $76.10 83
2023 Q3 693,020 $50,153,448 -$3,626,295 $72.37 80
2023 Q2 745,151 $56,357,411 -$7,382,718 $75.62 83
2023 Q1 839,413 $63,793,000 -$6,908,633 $76.00 85
2022 Q4 932,670 $73,302,527 +$1,249,570 $78.60 91
2022 Q3 939,516 $66,992,360 +$13,677,917 $71.30 77
2022 Q2 746,352 $55,956,836 +$1,565,275 $74.97 74
2022 Q1 713,465 $56,781,371 -$2,191,164 $79.59 79
2021 Q4 752,073 $60,990,245 -$12,062,440 $81.13 75
2021 Q3 901,505 $69,821,385 +$9,766,515 $77.37 91
2021 Q2 789,858 $63,562,513 -$381,587 $80.45 88
2021 Q1 794,981 $62,693,119 -$16,821,521 $78.88 86
2020 Q4 1,016,761 $72,629,765 -$5,493,688 $71.39 84
2020 Q3 1,089,490 $69,617,547 -$16,373,437 $63.87 81
2020 Q2 1,343,309 $86,946,346 +$1,160,615 $64.72 83
2020 Q1 1,328,522 $73,142,138 -$9,869,123 $55.01 79
2019 Q4 1,483,599 $96,008,774 -$37,621,459 $64.72 92
2019 Q3 2,025,934 $114,818,749 +$34,634,122 $56.66 79
2019 Q2 1,430,001 $86,027,552 +$22,413,357 $60.16 79
2019 Q1 1,042,400 $67,913,044 -$18,604,566 $65.17 89
2018 Q4 1,282,854 $80,042,370 -$524,720 $62.35 86
2018 Q3 1,344,651 $98,776,278 +$12,642,139 $73.49 86
2018 Q2 1,175,807 $79,111,976 +$79,107,074 $67.21 76
2018 Q1 73 $4,555 $0 $62.40 1
2017 Q4 73 $4,684 +$4,684 $64.16 1
2016 Q1 100 $7,000 $0 $70.00 1